Consensus statement on preventive and symptomatic care of leukodystrophy patients
- PMID: 25577286
- DOI: 10.1016/j.ymgme.2014.12.433
Consensus statement on preventive and symptomatic care of leukodystrophy patients
Abstract
Leukodystrophies are inherited disorders whose primary pathophysiology consists of abnormal deposition or progressive disruption of brain myelin. Leukodystrophy patients manifest many of the same symptoms and medical complications despite the wide spectrum of genetic origins. Although no definitive cures exist, all of these conditions are treatable. This report provides the first expert consensus on the recognition and treatment of medical and psychosocial complications associated with leukodystrophies. We include a discussion of serious and potentially preventable medical complications and propose several preventive care strategies. We also outline the need for future research to prioritize clinical needs and subsequently develop, validate, and optimize specific care strategies.
Keywords: Care; Consensus; Leukodystrophy; Outcomes; Prevention; Therapy.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Disease specific therapies in leukodystrophies and leukoencephalopathies.Mol Genet Metab. 2015 Apr;114(4):527-36. doi: 10.1016/j.ymgme.2015.01.014. Epub 2015 Feb 7. Mol Genet Metab. 2015. PMID: 25684057 Free PMC article.
-
Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies.Mol Genet Metab. 2017 Sep;122(1-2):18-32. doi: 10.1016/j.ymgme.2017.08.006. Epub 2017 Aug 20. Mol Genet Metab. 2017. PMID: 28863857 Free PMC article.
-
Case definition and classification of leukodystrophies and leukoencephalopathies.Mol Genet Metab. 2015 Apr;114(4):494-500. doi: 10.1016/j.ymgme.2015.01.006. Epub 2015 Jan 29. Mol Genet Metab. 2015. PMID: 25649058 Free PMC article. Review.
-
Adulthood leukodystrophies.Nat Rev Neurol. 2018 Feb;14(2):94-105. doi: 10.1038/nrneurol.2017.175. Epub 2018 Jan 5. Nat Rev Neurol. 2018. PMID: 29302065 Free PMC article. Review.
-
Hypomyelinating leukodystrophies - unravelling myelin biology.Nat Rev Neurol. 2021 Feb;17(2):88-103. doi: 10.1038/s41582-020-00432-1. Epub 2020 Dec 15. Nat Rev Neurol. 2021. PMID: 33324001 Review.
Cited by
-
Preserving Ambulation in a Gene Therapy-Treated Girl Affected by Metachromatic Leukodystrophy: A Case Report.J Pers Med. 2023 Apr 6;13(4):637. doi: 10.3390/jpm13040637. J Pers Med. 2023. PMID: 37109023 Free PMC article.
-
Novel and known morbidities of leukodystrophies identified using a phenome-wide association study.Neurol Clin Pract. 2020 Oct;10(5):406-414. doi: 10.1212/CPJ.0000000000000783. Neurol Clin Pract. 2020. PMID: 33299668 Free PMC article.
-
A hypomyelinating leukodystrophy in German Shepherd dogs.J Vet Intern Med. 2021 May;35(3):1455-1465. doi: 10.1111/jvim.16085. Epub 2021 Mar 18. J Vet Intern Med. 2021. PMID: 33734486 Free PMC article.
-
Genotypic and phenotypic characteristics of juvenile/adult onset vanishing white matter: a series of 14 Chinese patients.Neurol Sci. 2022 Aug;43(8):4961-4977. doi: 10.1007/s10072-022-06011-0. Epub 2022 Apr 7. Neurol Sci. 2022. PMID: 35389136 Review.
-
Adult Onset Vanishing White Matter Disease: A Rare Case Report.Cureus. 2022 Oct 11;14(10):e30177. doi: 10.7759/cureus.30177. eCollection 2022 Oct. Cureus. 2022. PMID: 36397907 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources